Johnson & Johnson takeover talk boosts Guidant price
This article was originally published in Clinica
Executive Summary
Guidant saw its shares climb 4.7% on July 27 as speculation over a merger with Johnson & Johnson stoked investor excitement. Both companies have reportedly declined to comment on the takeover rumours.